Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 238,196 | 109,833 | 44,298 | 98,637 | 123,080 |
| Marketable Securities | 73,442 | 139,123 | 221,412 | 241,299 | 262,293 |
| Receivables | 33,850 | 75,685 | 21,418 | 17,884 | 40,765 |
| TOTAL | $350,250 | $330,650 | $291,906 | $363,112 | $431,876 |
| Non-Current Assets | |||||
| PPE Net | 1,370 | 1,500 | 1,628 | 1,741 | 1,849 |
| Investments And Advances | 0 | 7,698 | 27,996 | 43,021 | 35,470 |
| Other Non-Current Assets | 12,775 | 13,250 | 13,720 | 14,179 | 14,639 |
| TOTAL | $14,145 | $22,448 | $43,344 | $58,941 | $51,958 |
| Total Assets | $364,395 | $353,098 | $335,250 | $422,053 | $483,834 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,871 | 2,893 | 3,329 | 6,123 | 4,002 |
| Accrued Expenses | 32,674 | 33,171 | 30,197 | 35,952 | 39,501 |
| TOTAL | $38,625 | $38,104 | $35,527 | $44,037 | $45,428 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 288,560 | 344,410 | 344,456 | 343,995 | 367,538 |
| TOTAL | $288,560 | $344,410 | $344,456 | $343,995 | $367,538 |
| Total Liabilities | $327,185 | $382,514 | $379,983 | $388,032 | $412,966 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,748 | 27,688 | 27,997 | 29,381 | 30,667 |
| Common Shares | 28 | 28 | 28 | 30 | 30 |
| Retained earnings | -772,559 | -822,173 | -837,286 | -798,656 | -759,327 |
| Other shareholders' equity | -24 | 47 | -6 | 161 | 305 |
| TOTAL | $37,210 | $-29,416 | $-44,733 | $34,021 | $70,868 |
| Total Liabilities And Equity | $364,395 | $353,098 | $335,250 | $422,053 | $483,834 |